CIC
ANIP icon

Cornercap Investment Counsel’s ANI Pharmaceuticals ANIP Stock Holding History

Cornercap Investment Counsel’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11,615
Closed -$740K – 527
2024
Q2 		$740K Sell
11,615
-110
-0.9% -$7.14K 0.12% 307
2024
Q1 		$811K Hold
11,725
– – 0.12% 306
2023
Q4 		$647K Hold
11,725
– – 0.11% 347
2023
Q3 		$681K Sell
11,725
-15
-0.1% -$866 0.12% 334
2023
Q2 		$632K Buy
11,740
+559
+5% +$24.8K 0.11% 344
2023
Q1 		$444K Buy
+11,181
New +$471K 0.08% 427
2021
Q3 		– Sell
-36,818
Closed -$1.29M – 539
2021
Q2 		$1.29M Buy
+36,818
New +$1.25M 0.14% 203
2021
Q1 		– Sell
-9,315
Closed -$574K – 529
2020
Q4 		$574K Buy
+9,315
New +$267K 0.08% 375
2020
Q2 		– Sell
-6,361
Closed -$259K – 424
2020
Q1 		$259K Sell
6,361
-4,714
-43% -$251K 0.05% 369
2019
Q4 		$683K Sell
11,075
-100
-0.9% -$6.62K 0.09% 358
2019
Q3 		$814K Sell
11,175
-13,630
-55% -$1.02M 0.12% 343
2019
Q2 		$2.04M Sell
24,805
-2,975
-11% -$212K 0.27% 117
2019
Q1 		$1.96M Sell
27,780
-1,175
-4% -$69.1K 0.27% 118
2018
Q4 		$1.3M Sell
28,955
-805
-3% -$42.2K 0.2% 150
2018
Q3 		$1.68M Buy
29,760
+4,685
+19% +$287K 0.22% 139
2018
Q2 		$1.68M Sell
25,075
-825
-3% -$51.5K 0.24% 122
2018
Q1 		$1.51M Buy
25,900
+14,650
+130% +$930K 0.21% 138
2017
Q4 		$725K Buy
+11,250
New +$700K 0.1% 316

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Cornercap Investment Counsel's ANIP Position: Q3 2024 in Review

Cornercap Investment Counsel sold out of ANI Pharmaceuticals (ANIP) in Q3 2024, closing a stake of 11,615 shares — an estimated $740K sold.

Cornercap Investment Counsel first reported a position in ANIP in Q4 2017 and held it in 18 quarters. The position peaked at $2.04M in Q2 2019. 208 funds tracked by Wall St. Rank hold ANIP as of Q3 2024.

  • Cornercap Investment Counsel reported no remaining ANI Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Cornercap Investment Counsel sold 11,615 ANI Pharmaceuticals shares in Q3 2024, an estimated $740K.
  • Cornercap Investment Counsel first reported a position in ANI Pharmaceuticals in Q4 2017 and held it in 18 quarters.
  • Cornercap Investment Counsel's ANI Pharmaceuticals position peaked at $2.04M in Q2 2019.
  • 208 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2024.

Based on Cornercap Investment Counsel's 13F filing for Q3 2024, filed 6 Nov 2024.